These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22718857)

  • 21. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
    Peukert S; Miller-Moslin K
    ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
    Zhang H; Sun Z; Liu Z; Song C
    Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoothened goes molecular: new pieces in the hedgehog signaling puzzle.
    McCabe JM; Leahy DJ
    J Biol Chem; 2015 Feb; 290(6):3500-7. PubMed ID: 25519909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.
    Frank-Kamenetsky M; Zhang XM; Bottega S; Guicherit O; Wichterle H; Dudek H; Bumcrot D; Wang FY; Jones S; Shulok J; Rubin LL; Porter JA
    J Biol; 2002 Nov; 1(2):10. PubMed ID: 12437772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
    Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS
    J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vismodegib, a small-molecule inhibitor of the hedgehog pathway for the treatment of advanced cancers.
    De Smaele E; Ferretti E; Gulino A
    Curr Opin Investig Drugs; 2010 Jun; 11(6):707-18. PubMed ID: 20496266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of Smoothened for therapeutic gain.
    Ruat M; Hoch L; Faure H; Rognan D
    Trends Pharmacol Sci; 2014 May; 35(5):237-46. PubMed ID: 24703627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties.
    Wang F; Stappenbeck F; Parhami F
    Cells; 2019 May; 8(5):. PubMed ID: 31137846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hedgehog Signaling and Truncated GLI1 in Cancer.
    Doheny D; Manore SG; Wong GL; Lo HW
    Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells.
    Ray A; Meng E; Reed E; Shevde LA; Rocconi RP
    Int J Oncol; 2011 Oct; 39(4):797-804. PubMed ID: 21701772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.
    Gonnissen A; Isebaert S; Haustermans K
    Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
    Li QR; Zhao H; Zhang XS; Lang H; Yu K
    Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
    Kiesslich T; Neureiter D
    Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
    Yun JI; Kim HR; Park H; Kim SK; Lee J
    Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.
    Baldanza VE; Rogic A; Yan W; Levine CB; Levine RA; Miller AD; McCleary-Wheeler AL
    PLoS One; 2020; 15(4):e0231762. PubMed ID: 32348319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
    Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
    J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hedgehog signal transduction network.
    Robbins DJ; Fei DL; Riobo NA
    Sci Signal; 2012 Oct; 5(246):re6. PubMed ID: 23074268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
    Blotta S; Jakubikova J; Calimeri T; Roccaro AM; Amodio N; Azab AK; Foresta U; Mitsiades CS; Rossi M; Todoerti K; Molica S; Morabito F; Neri A; Tagliaferri P; Tassone P; Anderson KC; Munshi NC
    Blood; 2012 Dec; 120(25):5002-13. PubMed ID: 22821765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth.
    Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W
    BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting GLI factors to inhibit the Hedgehog pathway.
    Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
    Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.